XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues:      
Subscription, transaction, and services $ 131,574 $ 108,569 $ 96,460
Reimbursable costs 34,831 37,116 40,008
Total revenues 166,405 145,685 136,468
Cost of revenues:      
Cost of subscription, transaction, and services 37,043 32,531 32,015
Cost of reimbursable costs 34,831 37,116 40,008
Total cost of revenues, excluding depreciation and amortization 71,874 69,647 72,023
Operating expenses:      
Research and development 50,127 36,468 34,285
Sales and marketing 39,624 23,420 22,098
General and administrative 48,282 22,188 23,297
Depreciation and amortization 5,516 5,624 5,881
Total operating expenses 143,549 87,700 85,561
Loss from operations (49,018) (11,662) (21,116)
Interest income 440 18 1
Interest expense and loss on extinguishment of debt (2,952) (4,661) (1,507)
Change in fair value of financial instruments and other expense (9,783) (518) (21)
Total other expense (12,295) (5,161) (1,527)
Loss before income taxes (61,313) (16,823) (22,643)
Income tax expense (benefit) (113) 204 160
Net loss $ (61,200) $ (17,027) $ (22,803)
Net loss per common share, basic (in USD per share) $ (0.39) $ (0.17) $ (0.23)
Net loss per common share, diluted (in USD per share) $ (0.39) $ (0.17) $ (0.23)
Weighted average common shares outstanding, basic (in shares) 155,066 100,023 99,272
Weighted average common shares outstanding, diluted (in shares) 155,066 100,023 99,272